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Abstract
Background:  Sub-optimal adherence to prescribed medications is well documented. Barriers to
medication adherence include medication side effects, cost, and forgetting to take or refill medications.
Interactive Voice Response (IVR) systems show promise as a tool for reminding individuals to take or refill
medications. This pilot study evaluated the feasibility and acceptability of using an IVR system for
prescription refill and daily medication reminders. We tested two novel features: personalized,
medication-specific reminder messages and communication via voice recognition.
Methods: Patients enrolled in a study of electronic prescribing and medication management in Quebec,
Canada who were taking chronic disease-related drugs were eligible to participate. Consenting patients
had their demographic, telephone, and medication information transferred to an IVR system, which
telephoned patients to remind them to take mediations and/or refill their prescriptions. Facilitators and
barriers of the IVR system use and acceptability of the IVR system were assessed through a structured
survey and open-ended questions administered by telephone interview.
Results: Of the 528 eligible patients who were contacted, 237 refused and 291 consented; 99 participants
had started the pilot study when it was terminated because of physician and participant complaints. Thirty-
eight participants completed the follow-up interview. The majority found the IVR system's voice
acceptable, and did not have problems setting up the time and location of reminder calls. However, many
participants experienced technical problems when called for reminders, such as incorrect time of calls and
voice recognition difficulties. In addition, most participants had already refilled their prescriptions when
they received the reminder calls, reporting that they did not have difficulties remembering to refill
prescriptions on their own. Also, participants were not receptive to speaking to an automated voice
system.
Conclusion: IVR systems designed to improve medication compliance must address key technical and
performance issues and target those individuals with reported memory difficulties or complex medication
regimens in order to improve the utility of the system. Future research should also identify characteristics
of medication users who are more likely to be receptive to IVR technology.
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Background
Sub-optimal adherence to prescribed medications is well
documented and has significant consequences for patient
health and care delivery [1-4]. On average, only half of all
prescribed medications are consumed by the patient [1].
In particular, poor medication adherence results in
increased utilization of health care resources and costs [5].
Barriers to medication adherence include medication side
effects [5], cost [5,6], and forgetting to take or refill medi-
cations [7]. Many interventions to improve medication
adherence have been targeted at reminding patients to
take their pills or refill prescriptions on time. However, a
review of interventions to improve medication adherence
in the elderly found that the use of reminders on medica-
tion packaging [8], reminder calendars[8], and mailed
reminders [9], did not did not improve medication adher-
ence over control groups. This review concluded that tele-
phone-based interventions showed the most promise in
improving medication adherence [8].
Interactive Voice Response (IVR) systems are a type of
computer-linked telephone intervention system that
could be used to provide efficient reminders to refill med-
ication. IVR can provide individualized messages to par-
ticipants and obtain feedback from participants'
responses through voice recognition or touchtone keypad.
IVR systems have shown potential for use as a tool in
health care. For example, IVR has been studied for use as
a reminder system to increase preventive screening and
vaccinations [10], as a means for screening adults, adoles-
cents, and high-risk pregnant women for depression [11-
13], for screening older adults for early signs of dementia
[14,15], for measuring drinking levels as part of an alco-
hol treatment program [16], and for preventing drinking
relapse in substance-abuse patients [17]. Generally these
studies have shown that patients can and will use IVR sys-
tems [12,16], that the information collected using IVR sys-
tems is reliable and valid when compared to paper-based
collection of information [11,13,15], and, in some stud-
ies, that the use of IVR has had a desired, positive effect on
participants' behaviour [10,18].
Despite these potential benefits, there have been few
attempts to use IVR to improve medication adherence
[19]. One promising study used a dial-in service to sup-
port self-management of hypertension [20]. Participants
phoned the service weekly to report medication adher-
ence, side effects, and blood pressure, and they received
educational messages regarding the benefits of medica-
tion adherence. The results showed increased adherence
and decreased blood pressure amongst those who
received the intervention and were not considered adher-
ent to medications at baseline [20]. However, because it
was up to the patients to call in to the system, the patients
who were most likely to call were probably the most likely
to benefit from the intervention. In addition, this type of
single-disease intervention is not well suited to individu-
als with multiple chronic conditions taking many medica-
tions.
One pilot study of 16 older adults tested the feasibility of
using IVR to improve medication adherence by asking
subjects to follow a complex, but hypothetical, medica-
tion regime [7]. Subjects were required to scan barcodes of
the pills they were scheduled to take at the times indicated
by the medication schedule. Those subjects who received
telephone reminders to scan their bar-coded medications
showed a significant improvement in their ability to fol-
low the simulated pill-taking instructions [7]. These
results from an IVR intervention tested in simulated med-
ication regimens are promising, but the IVR medication
reminders have not yet been validated in actual practice.
Additionally, more advanced methods such as voice rec-
ognition, which may increase accessibility for those with
limited manual dexterity or visual impairment, have not
been studied.
The purpose of this pilot study was to evaluate the feasi-
bility and acceptability of an IVR system for prescription
refill and daily medication reminders. This IVR system
provided two features not previously tested: personalized,
medication-specific reminder messages communicated to
participants currently on medications, and communica-
tion via voice recognition.
Methods
Context
The source population for this study was 13,278 patients
enrolled in the Medical Office of the 21st century program
(MOXXI) as of April 1st 2004. This ongoing research pro-
gram is evaluating the implementation and persistent use
of an electronic prescribing and medication management
application in a group of physicians based in a large urban
setting in Quebec, Canada. Participating physicians
obtain consent from their patients to access their personal
health information through the MOXXI system, including
their participation in various research projects aimed at
improving the safety and effectiveness of drug manage-
ment.
Unique to the MOXXI system is its real-time link with the
provincial health services insurance databases at la Régie
de l'assurance Maladie du Québec (RAMQ) which
includes the complete record of dispensed prescriptions
for all those registered with the public drug insurance plan
in Quebec, approximately 50% of the Quebec population
[21]. This feature enabled the implementation of an IVR
system for medication refill reminders since all patients
participating in the MOXXI program who were covered by
the public drug insurance plan had their complete medi-BMC Medical Informatics and Decision Making 2008, 8:46 http://www.biomedcentral.com/1472-6947/8/46
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cation profile readily available via the MOXXI system,
including the dispensing dates of prescriptions written by
all physicians for a particular patient.
Sample Selection
The current medications for all patients enrolled in the
MOXXI program were examined for the presence of drugs
used to treat cardiovascular, diabetes, thyroid and respira-
tory diseases. These drugs were targeted as patients gener-
ally take these medications for extended periods of time,
presenting opportunity for improving medication adher-
ence. Patients were deemed eligible to participate in the
pilot if they were dispensed at least one of these medica-
tions in the three months prior to the start of the pilot
study (April 2004). To be included patients were also
required to be publicly insured by the RAMQ in order to
ensure their prescription drug information was complete.
No other inclusion/exclusion criteria were used. Prior to
initializing the intervention, eligible MOXXI patients were
called to verify their interest in participating and to advise
them about the start of the intervention. All patients who
confirmed their consent then had their demographic, tel-
ephone, and medication information transferred to the
IVR system to conduct the initial registration process.
Intervention
An initial call was made by the IVR system to participants
to set up their individual preferences and to record their
voiceprint for identification purposes. Patients had the
option to choose the time of day when the IVR calls would
be made, what phone number should be called, and
whether they wanted daily medication reminders and pre-
scription refill reminders, or just prescription refill
reminders. The IVR system would then ask them to say
their name in order to record it for identification purposes
in subsequent calls. After initial set-up, daily updates were
provided to the IVR system on current medications for
each patient, including drug identification number and
name, and start and expected end-dates of current pre-
scriptions. The IVR system made calls to remind patients
to take mediations and/or refill their prescriptions accord-
ing to the preferences chosen by the participant and their
dispensed medication refill due dates. Reminder calls for
refilling prescriptions were made three days before the
end of participants' current prescription in order to give
participants enough time to get to the pharmacy for their
refill. Participants also had the option to have their pre-
scription refill request sent directly to the pharmacy, and
could also have the prescription delivered to their home.
Participants were free to call in to the system at any time
to change their preferences, temporarily stop the calls, or
withdraw from the program.
The IVR system used VoiceXML a special markup language
designed to facilitate the creation of interactive voice
response (IVR) services. It enabled the playing of speech
prompts using pre-recorded and text-to-speech informa-
tion, accepting spoken commands (via speech recogni-
tion) and the recording of caller audio information.
Following informed consent, the web server of the IVR
supplier (Tagge Medical Systems) was sent the patient
name, and their preferred telephone number. Once a
patient was registered in the IVR system, daily updates of
the medication(s) were sent to the IVR webserver. IVR
calls, interaction, and data collection were automated by
VoiceXML and pre-recorded scripts. The IVR system was
tested multiple times in-house by research staff prior to
pilot testing. Data obtained from the IVR system was
extracted and analysed by the research team.
Participant Feedback
Acceptability of the IVR system among participants was
assessed through a structured survey and open-ended
questions administered by telephone interview to identify
facilitators and barriers of the IVR system use. Participants
were asked about technical aspects of the system, such as
clarity and volume of the IVR voice, whether the calls were
made at the times requested, and whether the system
identified the correct medications to be reminded of or to
be refilled. Participants were also asked for feedback
regarding their understanding of the purpose of the calls
and the perceived usefulness of the IVR system for helping
them to remember to take/refill their medications.
Analysis
Descriptive statistics were used to summarize and com-
pare demographic and medication characteristics of par-
ticipants who completed the follow-up interview to those
who did not complete the follow-up interview, and also to
compare those who reported they found the intervention
helpful to those who did not. The open-ended interview
questions provided opportunities for participants to elab-
orate on issues raised in the structured survey and voice
their thoughts about the acceptability of the IVR system.
Participants' comments were analyzed using qualitative
data analysis techniques. This analysis involved categoriz-
ing responses to identify key aspects of the intervention's
design and implementation that affected participants' per-
ceptions of the overall utility of the system. Key facilitators
and barriers were identified by linking participants' com-
ments to their survey responses using a mixed method
approach to integrate the qualitative and quantitative data
[22].
Results
At the start of the study, 756 patients were eligible to par-
ticipate, of which 228 (30.2%) could not be reached due
to wrong numbers or no response upon repeated calls. Of
the 528 successfully contacted, 291 (55.1%) agreed to
participate in the pilot study and 237 (44.9%) refused. OfBMC Medical Informatics and Decision Making 2008, 8:46 http://www.biomedcentral.com/1472-6947/8/46
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those who agreed to participate, the first 99 (34.0%)
enrolled had their information sent to the IVR system
(Figure 1), and the first IVR call was made on April 17th,
2004. However, the pilot study terminated prematurely
after two months because of physician and participant
complaints. The follow-up interviews were conducted
with the first patients enrolled to evaluate the system.
Of the 99 participants in the pilot study, approximately
half were female (Table 1). Participants tended to be
older, with over 70% of participants being 70 years of age
or greater. The majority of participants (72.7%) spoke
French as their first language. On average, each participant
had 16 medications dispensed in the first month of the
study (April 2004), approximately 6 of which were for the
target chronic disease medications. A follow-up interview
was successfully completed with 38 of the initial 99 par-
ticipants (38.4%). Participants of the follow-up interview
were more likely to be female, age 80 years or older, and
to speak English as their first language, however the differ-
ences in age, gender, and language distributions were not
great (Table 1). Follow-up interview participants also had
a greater number of active prescriptions than non-partici-
pants, both when considering all types of drugs and when
considering targeted drugs for chronic diseases.
Participant understanding of the purpose of the IVR 
system
The majority of survey participants experienced some con-
fusion regarding the purpose of the initial IVR system call.
Twenty-one (57.6%) participants responded that they did
not understand what the call was about the first time the
IVR system contacted them (Table 2). Participants made
comments such as, "I did not understand anything; it was
confusing", "I didn't know what this was about at first"
and "I did not really understand what it was about
because I was not expecting this. It had been a long time
since I had signed up for the program." In contrast to these
individuals, those who reported understanding the pur-
pose of the IVR system phone calls said that either their
physician had explained the pilot study to them or pro-
Study population Figure 1
Study population. 1. 756 of the 993 had been called at the time when the pilot study was ended.
 
 
 
 
 
 
 
 
 
 
 
 
 
528 successfully contacted 
99 consented to participate 
and their information  had been 
forwarded to IVR system 
38 agreed to complete a follow-
up interview 
61 were not reached or 
refused to participate in the 
interview  
228 not successfully reached 
at time study was stopped 
237 refused to participate in 
the pilot study 
291 consented to participate in 
the pilot study 
192 their medication 
information had not yet been 
forwarded to IVR system 
when study stopped 
756 Called to obtain consent
1 
993 MOXXI patients eligible to 
receive IVR system reminders BMC Medical Informatics and Decision Making 2008, 8:46 http://www.biomedcentral.com/1472-6947/8/46
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vided them with adequate information about the pilot
study.
IVR system technical performance and design
The majority of survey participants (89.5%) found the
clarity of the IVR system's voice to be good or fair, and 34
(87.9%) found the volume of the IVR voice to be accepta-
ble. In the open-ended interview, only a few participants
made comments that "the words were not very clear or
distinct".
The system ran relatively smoothly with regards to setting
up the time and location of reminder calls. Among the 28
(73.7%) who had received a call from the IVR system at
the time of the interview, 24 (85.7%) reported that they
did not have trouble setting up the time and location of
their reminder calls.
However, there were many major technical and perform-
ance issues reported by participants. Only 6 (21.0%) par-
ticipants responded that the calls came at the time of day
they had requested. Many patients interviewed men-
tioned they received calls too late in the evening; partici-
pants commented "I got a call at 12:00 a.m!", "I received
two reminder calls at 1:30 a.m. and did not appreciate
that", and "one time, I received a call at 11:00 p.m. and
that made me think about dropping the program. That
was not considerate." In addition, there were problems
with system design: some participants were not happy
with the frequency of calls received. In the open-ended
interviews, participants reported that the system called to
remind them regarding every pill, which for some was
"too much" because they were on many medications.
Another major performance issue was that the voice rec-
ognition feature of IVR system had difficulty recognizing
Table 1: Characteristics of the 99 patients who participated in the IVR pilot study
Participated in follow-up survey:
Yes (N = 38) No (N = 61) All (N = 99)
N% N% N %
Female 20 52.6 27 44.3 47 47.5
Male 18 47.4 34 55.7 52 52.5
< 60 yrs 2 5.3 5 8.2 7 7.1
60–69 yrs 71 8 . 4 1 42 3 . 0 2 1 2 1 . 2
70–79 yrs 17 44.7 28 45.9 45 45.5
> 80 yrs 12 31.6 14 23.0 26 26.3
Primary language:
French 24 63.2 48 78.7 72 72.7
English 14 36.8 13 21.3 27 27.3
Mean SD Mean SD Mean SD
Active prescriptions 16.4 14.1 15.9 13.0 16.1 13.3
Active prescriptions for chronic disease targeted by study 5.2 3.8 5.9 4.8 5.6 4.4
Table 2: Participants' opinion regarding the set-up, timing, and accuracy of reminder calls
Survey Responses:
Yes No Don't Remember
Interview questions: N%N% N %
A. Did you understand what the automated telephone call was about? 17 44.7 21 55.3
B. Did you receive a reminder call from the IVR system? 28 73.7 10 26.3
The following questions pertain only to those who answered yes to having received a reminder call (n = 28):
C. Did you have any difficulty setting up the time and location of the reminder call? 4 14.3 24 85.7
D. Did the reminder call come in at the time you requested? 8 29.0 6 21.0 14 50.0
E. Was the name of the medication(s) to be refilled correct?1 18 78.3 0 0.0 5 21.7
F. When the reminder call came, had you already refilled your prescription? 20 71.4 8 28.6
G. Did you find the call system helpful for remembering to refill your prescription? 4 14.3 24 85.7
15 participants did not answer this questionBMC Medical Informatics and Decision Making 2008, 8:46 http://www.biomedcentral.com/1472-6947/8/46
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participants' voices. This caused much frustration for par-
ticipants, who expressed that "the machine would not
catch the yes or the no and sometimes would give an off
response", "the machine made you sound stupid because
it would ask you to answer even when you already had. It
was confusing and would not listen to you and repeat the
same thing", and that "it went very quick, did not give you
any chances and would just bark something out at you."
Acceptance of IVR technology
It was evident from the analysis of participants' comments
from the open-ended questions that many participants
were not receptive to the IVR technology. One reason was
a frustration with not being able to talk to a real person: "I
was irritated because I could not really speak to anybody
and/or ask questions", "sometimes the calls were annoy-
ing and talking to a machine was not helpful", and "a
machine is a machine. There is nothing human about
that. I'd rather talk to a real person." In addition, some
expressed discomfort with the technology in general, stat-
ing "it was intimidating because a computer was talking",
"I don't need anything that's automatic", and that "the
system was a failure and I had a terrible experience. The
person who designed it had no humanistic understand-
ing."
IVR system utility
Twenty (71.4%) interview participants responded that
they had already filled their medication prescription at the
time they had received the IVR reminder call (Table 2).
This issue was also identified by comments participants
made during the follow-up interview. Participants stated
"I don't need to be reminded, I am not senile yet", "we
only have a certain number of pills to take and we remem-
ber them", and "it (the IVR system) does not do anything
for me. It is useless because I take care of it myself. When
there are only a couple of pills left, I go to the pharmacy.
It is part of my routine." The general attitude of most par-
ticipants was that they did not have trouble remembering
to take medications or refill medication prescriptions.
Only 4 participants (14.3%) responded that they found
the system helpful for remembering to refill their prescrip-
tions. However, many did indicate that this intervention
could be helpful for those who do have difficulties
remembering, stating "it is not useful now, maybe later or
for others", and that the IVR system "seemed like a good
idea for others but not for me."
Comparing those who found the IVR system helpful with 
those who did not
In an attempt to identify characteristics of those who
would find an IVR system most useful for remembering to
take medications or refill prescriptions, those who
responded that they found the system helpful for remem-
bering to refill prescriptions were compared to those who
responded that they did not find the system helpful
Although significant differences between the two groups
could not be determined due to the small sample size,
there appeared to be a trend that participants who found
the system helpful were more likely to be older and to
have more active prescriptions. In addition, all four partic-
ipants who found the system helpful understood that the
IVR calls were to remind them to take or refill medication
the first time the system called, whereas only 9 of the 24
who did not find the system helpful understood the pur-
pose of the first IVR calls. Both groups encountered tech-
nical difficulties and expressed frustration with the IVR
system in the open-ended interview, but those who found
the system helpful for remembering to refill prescriptions
made comments such as "(the IVR system) is a good idea,
not because I forget but because it is good to be reminded"
and "moderately (helpful), keeps track of pills", and also
reported fewer negative comments overall than those who
did not find the IVR system helpful.
Discussion
IVR systems have the potential to enhance medication
adherence for chronic conditions by providing medica-
tion and prescription refill reminders. However, this study
identified difficulties in successfully implementing an IVR
system for refill reminders in a population of persons tak-
ing medications for chronic diseases.
In order to use IVR systems efficiently, the population tar-
geted for the intervention must be one where there is suf-
ficient opportunity for the intervention to have an effect.
In this study all persons on chronic disease-related medi-
cations were targeted for participation, but the results of
the structured survey and open-ended questions indicated
that this population may not have been in need of IVR
medication reminders. Most participants responded that
they did not have difficulties remembering to take medi-
cations or to get prescriptions refilled; in other words, they
were still able to manage their medications independ-
ently. As a result, only four of the 28 participants who
were interviewed and received reminder calls found the
system helpful. In order to use IVR systems effectively as
medication reminder systems in future studies, only those
already having medication compliance problems due to
forgetting to take or refill medications should be targeted
for receiving the IVR system intervention.
Some of the technical and system design problems
encountered could be addressed easily with system adjust-
ments. For example, the frequency with which the IVR sys-
tem was calling participants could easily be changed by
adjusting the system so that it would recognize when mul-
tiple prescriptions for the same person needed to be
refilled within a short time period and to call only once
for all mediations. In addition, creating an option for par-BMC Medical Informatics and Decision Making 2008, 8:46 http://www.biomedcentral.com/1472-6947/8/46
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ticipants to be called only for medications selected by
either the patient or his/her physician could help resolve
this issue.
The other major technical problem was the difficulty the
voice response technology had recognizing participants'
voices. The investigators discovered that the system had
trouble recognizing a participant's voice if they were
responding on a cordless phone but had created their
voiceprint on a land line, or vice-versa. A simple solution
to this problem would be to emphasize to participants to
complete the voiceprint on the phone they are most likely
to answer. In addition, the system often incorrectly recog-
nized AM as PM and or PM as AM, and therefore called
participants at inappropriate times. To solve all voice rec-
ognition problems key-pad response ability could be
added to the system for times when the voice recognition
fails. However, this doesn't address the goal of increasing
accessibility of the system for those with limited manual
dexterity or visual impairment. The best solution would
be an improvement in speech recognition technology
before re-piloting this type of intervention, which has
been the case in recent IVR industry trends; speech recog-
nition technology has improved greatly, now showing
speech recognition accuracy rates between 90%–96%
[23].
Issues such as resistance to IVR technology may limit the
utility of this technology for many patients. Participants'
feedback indicated that they found talking to an auto-
mated voice impersonal and awkward. This raises the
question of the acceptability in general of health-related
interventions that involve speaking to an automated
voice, even with improvements in voice recognition tech-
nology and targeting the intervention to a population
showing the greatest opportunity for the intervention to
have an effect. Adding the option of key-pad responses
may improve this acceptability. In addition, identifying
characteristics of those who are more receptive to IVR
technology and targeting this group is vital to effective
implementation of IVR systems.
One limitation of this study was the small sample size. It
is known that those who consent to participate in health
research are often healthier than those who refuse. In this
case, those who participated would be more likely to com-
ply with their medication regimes, leading to an underes-
timation of the effectiveness of the intervention. On the
other-hand, this self-selected group may also be more
open to new technologies than those who refuse to partic-
ipate, leading to an underestimation of the negative reac-
tion found in this study to IVR technology. Therefore,
although negative perceptions of the technology may be
underestimated, the usefulness of the intervention may
also be underestimated.
With only 38 people participating in the follow-up inter-
view and only four responding that they thought the sys-
tem was helpful, results relating to identifying
characteristics of those receptive to IVR technology can be
considered as trends to be investigated in future research;
we cannot draw conclusions about the best target popula-
tion for this intervention. However, it is interesting to
note that all of the participants who reported the system
as helpful understood what the IVR system was calling
about the first time they received a call, whereas the
majority of those who did not find the system helpful did
not understand the purpose of the first IVR system phone
call. If the amount of confusion regarding the IVR system
phone calls could be reduced, more participants would
find the system helpful. To reduce confusion, the initial
IVR system call to set up individual preferences and voice-
prints could be completed immediately after consent, fol-
lowed by a call from a health team member to address any
problems or questions about the set-up. An option to
"zero out" (dial zero) during the phone call in order to
reach a health team member could also help address con-
fusion and questions during any IVR system call. Never-
theless, future research should attempt to identify more
characteristics of those receptive to IVR technology.
As demonstrated, there were many technical issues discov-
ered during implementation, even though the IVR system
had been tested in-house by research staff multiple times
before initiating the pilot study. This made it difficult to
differentiate participant frustration regarding the techni-
cal functioning of the IVR system from participant resist-
ance to the IVR system itself. Having a technically flawless
system is therefore of utmost importance in determining
the true ability of participants to accept an IVR system
intervention.
Conclusion
The goal of this pilot study was to evaluate the feasibility
and acceptability of an IVR system for prescription refill
and daily medication reminders in an ambulatory, pri-
mary care setting that provided two features not previ-
ously tested: medication-specific reminders for
participants following real medication regimens, and
communication via voice recognition. The medication-
specific reminders, although generally not perceived as
being helpful for this pilot study's population, were
thought to be potentially helpful for those currently hav-
ing difficulties remembering to take or refill medications.
The voice recognition technology did not function prop-
erly, and therefore it was difficult to determine if the neg-
ative reception of the technology by participants was
mainly due to the many technical flaws, a dislike for the
technology itself, or both. In order to improve the imple-
mentation, utility, and acceptance of IVR systems, they
should have solid technical performance and systemPublish with BioMed Central    and   every 
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design, and be implemented in a population where there
is opportunity for the intervention to have an effect and
where there is a willingness to accept new technology.
Once these criteria have been satisfied, IVR systems have
the potential to find their niche in the health care system
as efficient and effective tools for improving medication
compliance through medication and prescription refill
reminders.
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